Filter
27
Filtered Results: 27
Text search:
nirmatrelvir
Featured
Recommendations
12
Language
Document type
Fact sheets
11
Guidelines
8
Studies & Reports
4
Strategic & Response Plan
2
Manuals
1
No document type
1
Countries / Regions
Global
3
Latin America and the Carribbean
3
Authors & Publishers
Publication Years
Category
COVID-19
2
Non-communicable Diseases
2
Infection Control & Prevention (IPC)
1
Guidelines
1
Studies & Reports
1
Statistics
1
Pharmacy & Technologies
1
Toolboxes
Clinical Guidelines
18
COVAX Initiative
2
Situation Reports & Updates
1
Global Impact: Socio-economic, health services, TB & HIV
1
Access & Strategy
1
Fair Allocation & Ethical Aspects
1
SARS-CoV-2 Variants
1
Essential Medicines
1
Prices and Patents
1
Reports & Studies
1
Prevention & Strategies
1
Clinical Aspects & Diagnosis
1
Global Overview
1
Human Rights & the Right to Health
1
31 Oct 2022 his plan outlines how the ACT-Accelerator will support countries as the world transitions to long-term COVID-19 control.
Recognizing the evolving nature of the COVID-19 virus and pandemic, the plan outlines changes to ACT-A’s set-up and ways of working, to ensure countries co...
This report’s central premise is that diagnostics and therapeutics, and associated test to treat strategies, are fundamental components of the pandemic response, both for COVID-19 and for future health threats. Two years into the COVID-19 pandemic, this report reflects on the main challenges and k...
The objective of Health in the Americas: Overview of the Region of the Americas in the Context of the COVID-19 Pandemic is to respond to the need to address important public health issues in an increasingly timely manner, while serving as a platform with a close focus on specific issues of regional ...
3 March 2022
The WHO Therapeutics and COVID-19: living guideline contains the Organization’s most up-to-date recommendations for the use of therapeutics in the treatment of COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an ...
The two-year impact report for the Access to COVID-19 Tools (ACT) Accelerator details impact, case studies and timelines of key milestones for the Diagnostics, Therapeutics and Vaccines pillars, as well as the Health Systems and Response Connector.
Ongoing Living Update of COVID-19 Therapeutic Options: Summary of Evidence, Rapid Review 22 February 2022
recommended
This document includes the results of a rapid systematic review of current available literature. The information included in this review reflects the evidence as of the date posted in the document. In recognition of the fact that there are numerous ongoing clinical studies, PAHO will periodically up...
21 January 2022
The overall threat posed by Omicron largely depends on four key questions: (i) how transmissible the variant is; (ii) how well vaccines and prior infection protect against infection, transmission, clinical disease and death; (iii) how virulent the variant is compared to other varian...
